EP-1272: Gold seed markers in prostate bed image-guided radiotherapy  by Ålander, E. et al.
S478  2nd ESTRO Forum 2013 
EP-1272   
Gold seed markers in prostate bed image-guided radiotherapy 
E. Ålander1, H. Visapää1, J. Keyriläinen1, M. Kouri1, M. Tenhunen1 
1Helsinki University Central Hospital, Radiotherapy, Helsinki, Finland  
 
Purpose/Objective: This study aimed to investigate the magnitude of 
interfraction prostate bed motion and delineate reasonable CTV-PTV 
margins in situations where image-guided localization is performed 
using an analysis of bony anatomy landmarks or gold seed fiducial 
markers and in situation where image-guidance is applied more 
sparsely and patient set-up is done according to patient’s skin marks. 
Materials and Methods: Thirteen prostate cancer patients, who had 
been implanted four gold seed fiducials into their prostate bed, were 
imaged daily by cone beam CT (CBCT) before radiotherapy. In total, 
466 CBCT images were analyzed and total position error, set-up error 
and prostate bed motion were measured by analyzing the position of 
gold seed fiducials and locations of bony anatomy landmarks. 
Systematic and random errors were calculated and CTV-PTV margins 
were determined for the situation where 1) the fractions are 
delivered according to patient’s skin marks, 2) the IGRT is performed 
for the first three treatment fractions, whereas the rest of the 
fractions are delivered according to patient’s offset skin marks, and 3) 
the IGRT is executed daily and the localization is based on bony 
anatomy landmarks. 
Results: CTV-PTV margins were 4.9 mm in the left-right (LR) axes, 8.0 
mm in the superior-inferior (SI) axes and 7.4 mm in the anterior-
posterior (AP) axes when the localization was done aligning to skin 
marks (i.e. without the IGRT). If imaging was performed on the first 
three treatment fractions and the rest of the fractions were treated 
according to patient’s offset skin marks, the margins were 2.4 mm, 
6.5 mm and 6.6 mm in the LR, SI and AP axes, respectively. If daily 
IGRT was performed and localization was done by bony anatomy 
landmarks, margins were 1.4 mm, 5.9 mm and 5.9 mm in the LR, SI 
and AP axes, respectively. 
Conclusions: Daily pre-treatment CBCT can reduce CTV-PTV margins 
for 72%, 26% and 20% in the LR, SI and AP axes, respectively. Prostate 
bed motion seems to have a relatively more significant impact to the 
SI and AP margins when compared to set-up error, which has more 
important role in the LR margin. The alignment of bony anatomy 
landmarks on daily basis does not reduce margins significantly hence it 
is reasonable to use imaging more sparsely in that case. In daily IGRT 
either the use of CBCT or the gold seed fiducial localization seems 
profitable.  
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Purpose/Objective: Advances in radiotherapy technology have sought 
to mitigate the effects of patient movement, organ motion and 
anatomical deformation on the efficacy of treatment delivery [1]. The 
irradiation of abdominal tumours such as Neuroblastoma in paediatric 
patients presents a challenge to deliver an adequate dose to the 
target dose whilst minimising dose to surrounding tissues. The 
majority of the published data for motion for abdominal organs have 
been acquired from the adult population [2][3]. Paediatric data is 
limited to one article on 4DCT on 20 free-breathing patients and a 
second evaluating CBCT for 9 patients under general anaesthesia 
[4][5]. 
References available on request. 
Materials and Methods: The radiotherapy database was reviewed to 
extract those paediatric patients that were treated for abdominal 
tumours with Intensity Modulated radiotherapy with Cone Beam CT 
(CBCT) verification during treatment for 2011/2012. The CBCT scans 
were then ‘co-registered’ to the vertebral bones of the reference 
helical planning CT within the ECLIPSE v10.0 planning system (Varian 
Medical Systems) in order to demonstrate soft tissue motion relative 
to the planning CT. In ECLIPSE, both kidneys were then re-delineated 
from the matched dataset onto the reference planning scan. In 
addition, areas of bowel gas were re-delineated in the same fashion. 
The re-delineated volumes were compared for changes in ‘apparent’ 
volume and centre of mass. The dosimetric effect of these changes 
was also calculated. 
Results: Six paediatric patients were able to be included in this 
review with a total of 31 CBCT scans. Each patient had at least one 
CBCT acquired per week. All patients demonstrated ‘apparent’ kidney 
volumes different from the planning ct. Range of kidney volume 
change (All CBCTs): [-0.3% (±5.2) to +27.0% (±14.0)] . Maximum Centre 
of Mass change vector: [+0.9cm (±0.3cm)]. The principal direction of 
kidney motion is in the cranial-caudal direction as described by other 
authors. All patients also demonstrated large variations in bowel gas 
volume and distribution. Anatomical positional variations and bowel 
gas changes led to changes in delivered dose to Organs at Risk. 
Conclusions: Highly conformal plans based on a helical CT in this 
patient cohort may not be able to deliver the planned dose due to the 
variations in anatomy described. Methods to characterise the motion 
such as 4dCT or limit the motion such as abdominal compression 
should be considered. Interventions such as those used in the adult 
practice to reduce the impact of bowel gas should be evaluated for 
suitability in this population. Reduction in bowel gas will improve 
CBCT image quality. Linac-based CBCT verification strategies must 
also be investigated to reduce potential dosimetric variation.  
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Purpose/Objective: Validate an in-house deformable registration 
algorithm in order to calculate the 'dose of the day' and assess the 
need to replan head and neck (HN) patients, by deforming a planning 
CT (pCT) to match the daily CBCT scan. 
Materials and Methods: Data from 3 HN patients treated in our clinic 
was used in this study. These patients considerably changed shape 
throughout their treatment and therefore required replan midway. 
Therefore, in addition to the pCT and weekly CBCTs, a rescan CT (rCT) 
was also available. We register the pCT to a CBCT using an open-
source deformable registration algorithm developed at our institution 
(NifTK). Two tests were performed to assess the quality of our 
registrations: (i) structures delineated in the pCT were warped and 
compared with contours manually drawn by the same physician on the 
CBCT and (ii) dose calculations for the same IMRT plan on the 
deformed CT and rescan CT (rCT) were compared. The structure set 
used on the first test was a mixture of bone and soft tissue structures, 
such as vertebras and neck muscles, which can be seen unequivocally 
on the pCT and CBCT. Since the rCT and following CBCT are acquired 
5-7 days apart, they do not represent the same geometry. To 
minimize errors in the dose calculation due to inaccuracy in 
representing the real geometry, we actually registered the pCT to a 
simulated CBCT, obtained from deforming the real CBCT to match the 
rCT. This simulated CBCT is a better representation of an ideal 
dataset, in which the rCT and CBCT would have been acquired at the 
same time. The dose distributions were compared using dose-
difference (DD), gamma analysis (γ), target coverage (using isodose 
surfaces) and DVHs. 
Results: The warped structures showed a good agreement with the 
manually drawn ones, with more than 90% of the warped surface 
pixels being distanced less than 2mm off the manually drawn ones. 
The dose distributions were compared within a region of interest that 
contained the rCT body that received dose plus a 5mm margin. The 
dose to critical structures, such as parotids, brainstem and spinal 
canal, was also assessed. The mean DD value was less than 1% of the 
prescribed dose and 92.6% of the voxels have a DD less than 2% of the 
prescribed dose. The gamma analysis of the dose distributions passed 
with 96-98% of the voxels agreeing within 2% DD and 2mm distance-to-
agreement (DTA). The 95% isodose surfaces were shown to have a 
mean dice similarity index (DSI) and overlap index (OI) of 0.959 and 
0.971 respectively. DVHs were found to be in good agreement for the 
brainstem, spinal cord and parotids curves. The relative error 
estimating the absolute dose to the brainstem and spinal canal is 
4.20% and 0.35% on the deformed dataset. 
Conclusions: Our preliminary results indicate that pCT to CBCT 
deformable registration can be used to estimate the 'dose of the day'. 
The structures of interest warped from the pCT can be used to 
compute daily DVHs. This strategy has potential clinical use to 
evaluate the need for a replan without significant increased workload 
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